Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 194

2.

Institutional Incentives for Mentoring at the U.S. Department of Veterans Affairs and Universities: Associations With Mentors' Perceptions and Time Spent Mentoring.

Maisel NC, Halvorson MA, Finney JW, Bi X, Hayashi KP, Blonigen DM, Weitlauf JC, Timko C, Cronkite RC.

Acad Med. 2017 Apr;92(4):521-527. doi: 10.1097/ACM.0000000000001507.

PMID:
28351065
3.

Predictive Validity of Outpatient Follow-up After Detoxification as a Quality Measure.

Schmidt EM, Gupta S, Bowe T, Ellerbe LS, Phelps TE, Finney JW, Humphreys K, Trafton J, Vanneman ME, Harris AHS.

J Addict Med. 2017 May/Jun;11(3):205-210. doi: 10.1097/ADM.0000000000000298.

PMID:
28282324
4.

Predictive validity of a quality measure for intensive substance use disorder treatment.

Schmidt EM, Gupta S, Bowe T, Ellerbe LS, Phelps TE, Finney JW, Asch SM, Humphreys K, Trafton J, Vanneman M, Harris AHS.

Subst Abus. 2017 Jul-Sep;38(3):317-323. doi: 10.1080/08897077.2016.1212779. Epub 2016 Jul 19.

PMID:
27435754
5.

Excellent Patient Care Processes in Poor Hospitals? Why Hospital-Level and Patient-Level Care Quality-Outcome Relationships Can Differ.

Finney JW, Humphreys K, Kivlahan DR, Harris AH.

J Gen Intern Med. 2016 Apr;31 Suppl 1:74-7. doi: 10.1007/s11606-015-3564-3. Review.

6.

The Changing Faces of Mentorship: Application of a Developmental Network Framework in a Health Services Research Career Development Program.

Halvorson MA, Finney JW, Bi X, Maisel NC, Hayashi KP, Weitlauf JC, Cronkite RC.

Clin Transl Sci. 2015 Dec;8(6):824-9. doi: 10.1111/cts.12355. Epub 2015 Dec 10.

7.

Toward cost-effective staffing mixes for Veterans Affairs substance use disorder treatment programs.

Im JJ, Shachter RD, Finney JW, Trafton JA.

BMC Health Serv Res. 2015 Nov 23;15:515. doi: 10.1186/s12913-015-1175-7.

8.

Evaluating the Productivity of VA, NIH, and AHRQ Health Services Research Career Development Awardees.

Finney JW, Amundson EO, Bi X, Cucciare MA, Eisen SA, Finlay AK, Halvorson MA, Hayashi K, Owens DK, Maisel NC, Timko C, Weitlauf JC, Cronkite RC.

Acad Med. 2016 Apr;91(4):563-9. doi: 10.1097/ACM.0000000000000982.

PMID:
26556291
9.

Predictive validity of two process-of-care quality measures for residential substance use disorder treatment.

Harris AH, Gupta S, Bowe T, Ellerbe LS, Phelps TE, Rubinsky AD, Finney JW, Asch SM, Humphreys K, Trafton J.

Addict Sci Clin Pract. 2015 Oct 31;10:22. doi: 10.1186/s13722-015-0042-5.

10.

Guidelines for the Reporting of Treatment Trials for Alcohol Use Disorders.

Witkiewitz K, Finney JW, Harris AH, Kivlahan DR, Kranzler HR.

Alcohol Clin Exp Res. 2015 Sep;39(9):1571-81. doi: 10.1111/acer.12797. Epub 2015 Aug 11. Review.

11.

Recommendations for the Design and Analysis of Treatment Trials for Alcohol Use Disorders.

Witkiewitz K, Finney JW, Harris AH, Kivlahan DR, Kranzler HR.

Alcohol Clin Exp Res. 2015 Sep;39(9):1557-70. doi: 10.1111/acer.12800. Epub 2015 Aug 6. Review.

12.

What ecologic analyses cannot tell us about medical marijuana legalization and opioid pain medication mortality.

Finney JW, Humphreys K, Harris AH.

JAMA Intern Med. 2015 Apr;175(4):655-6. doi: 10.1001/jamainternmed.2014.8006. No abstract available.

PMID:
25844747
13.

Examining the Specification Validity of the HEDIS Quality Measures for Substance Use Disorders.

Harris AH, Ellerbe L, Phelps TE, Finney JW, Bowe T, Gupta S, Asch SM, Humphreys K, Trafton J.

J Subst Abuse Treat. 2015 Jun;53:16-21. doi: 10.1016/j.jsat.2015.01.002. Epub 2015 Jan 15.

PMID:
25736624
14.

Brief interventions for alcohol misuse.

Moyer A, Finney JW.

CMAJ. 2015 Apr 21;187(7):502-506. doi: 10.1503/cmaj.140254. Epub 2015 Mar 2. Review. No abstract available.

15.

State-level relationships cannot tell us anything about individuals.

Harris AH, Humphreys K, Finney JW.

Am J Public Health. 2015 Apr;105(4):e8. doi: 10.2105/AJPH.2015.302604. Epub 2015 Feb 25. No abstract available.

16.

Ten-Year Publication Trajectories of Health Services Research Career Development Award Recipients: Collaboration, Awardee Characteristics, and Productivity Correlates.

Halvorson MA, Finlay AK, Cronkite RC, Bi X, Hayashi K, Maisel NC, Amundson EO, Weitlauf JC, Litt IF, Owens DK, Timko C, Cucciare MA, Finney JW.

Eval Health Prof. 2016 Mar;39(1):49-64. doi: 10.1177/0163278714542848. Epub 2014 Jul 11.

PMID:
25015081
17.

A meta-analysis of topiramate's effects for individuals with alcohol use disorders.

Blodgett JC, Del Re AC, Maisel NC, Finney JW.

Alcohol Clin Exp Res. 2014 Jun;38(6):1481-8. doi: 10.1111/acer.12411. Epub 2014 May 5.

18.

Intention-to-treat analyses and missing data approaches in pharmacotherapy trials for alcohol use disorders.

Del Re AC, Maisel NC, Blodgett JC, Finney JW.

BMJ Open. 2013 Nov 12;3(11):e003464. doi: 10.1136/bmjopen-2013-003464.

19.
20.

How effective is continuing care for substance use disorders? A meta-analytic review.

Blodgett JC, Maisel NC, Fuh IL, Wilbourne PL, Finney JW.

J Subst Abuse Treat. 2014 Feb;46(2):87-97. doi: 10.1016/j.jsat.2013.08.022. Epub 2013 Sep 26. Review.

21.

Placebo group improvement in trials of pharmacotherapies for alcohol use disorders: a multivariate meta-analysis examining change over time.

Del Re AC, Maisel N, Blodgett JC, Wilbourne P, Finney JW.

J Clin Psychopharmacol. 2013 Oct;33(5):649-57. doi: 10.1097/JCP.0b013e3182983e73. Review.

22.

Receipt of cervical cancer screening in female veterans: impact of posttraumatic stress disorder and depression.

Weitlauf JC, Jones S, Xu X, Finney JW, Moos RH, Sawaya GF, Frayne SM.

Womens Health Issues. 2013 May-Jun;23(3):e153-9. doi: 10.1016/j.whi.2013.03.002.

23.

Extent and reporting of patient nonenrollment in influential randomized clinical trials, 2002 to 2010.

Humphreys K, Maisel NC, Blodgett JC, Fuh IL, Finney JW.

JAMA Intern Med. 2013 Jun 10;173(11):1029-31. doi: 10.1001/jamainternmed.2013.496. No abstract available.

24.

Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?

Maisel NC, Blodgett JC, Wilbourne PL, Humphreys K, Finney JW.

Addiction. 2013 Feb;108(2):275-93. doi: 10.1111/j.1360-0443.2012.04054.x. Epub 2012 Oct 17. Review.

25.

Cross-level bias and variations in care.

Finney JW, Humphreys K, Harris AH.

JAMA. 2011 Nov 16;306(19):2096-7; author reply 2097. doi: 10.1001/jama.2011.1662. No abstract available.

PMID:
22089717
26.

How do components of evidence-based psychological treatment cluster in practice? A survey and cluster analysis.

Gifford EV, Tavakoli S, Weingardt KR, Finney JW, Pierson HM, Rosen CS, Hagedorn HJ, Cook JM, Curran GM.

J Subst Abuse Treat. 2012 Jan;42(1):45-55. doi: 10.1016/j.jsat.2011.07.008. Epub 2011 Sep 22.

PMID:
21943809
27.

Why health care process performance measures can have different relationships to outcomes for patients and hospitals: understanding the ecological fallacy.

Finney JW, Humphreys K, Kivlahan DR, Harris AH.

Am J Public Health. 2011 Sep;101(9):1635-42. doi: 10.2105/AJPH.2011.300153. Epub 2011 Jul 21.

28.

Longer length of stay is not associated with better outcomes in VHA's substance abuse residential rehabilitation treatment programs.

Harris AH, Kivlahan D, Barnett PG, Finney JW.

J Behav Health Serv Res. 2012 Jan;39(1):68-79. doi: 10.1007/s11414-011-9250-2.

PMID:
21732222
29.

Implementing evidence-based psychosocial treatment in specialty substance use disorder care.

Manuel JK, Hagedorn HJ, Finney JW.

Psychol Addict Behav. 2011 Jun;25(2):225-37. doi: 10.1037/a0022398. Review.

30.

Introduction to a special section on implementing evidence-based interventions for substance use disorders.

Finney JW, Hagedorn HJ.

Psychol Addict Behav. 2011 Jun;25(2):191-3. doi: 10.1037/a0023949.

PMID:
21668084
31.

Alcoholics Anonymous attendance, decreases in impulsivity and drinking and psychosocial outcomes over 16 years: moderated-mediation from a developmental perspective.

Blonigen DM, Timko C, Finney JW, Moos BS, Moos RH.

Addiction. 2011 Dec;106(12):2167-77. doi: 10.1111/j.1360-0443.2011.03522.x. Epub 2011 Sep 21.

32.

Commentary on Lopez-Quintero et al. (2011): Remission and relapse - the Yin-Yang of addictive disorders.

Moos RH, Finney JW.

Addiction. 2011 Mar;106(3):670-1. doi: 10.1111/j.1360-0443.2010.00003284.x. No abstract available.

PMID:
21299675
33.

Meeting the challenges for research and practice for brief alcohol intervention.

Moyer A, Finney JW.

Addiction. 2010 Jun;105(6):963-4; discussion 964-5. doi: 10.1111/j.1360-0443.2010.02907.x. No abstract available.

PMID:
20659056
34.

Sexual violence, posttraumatic stress disorder, and the pelvic examination: how do beliefs about the safety, necessity, and utility of the examination influence patient experiences?

Weitlauf JC, Frayne SM, Finney JW, Moos RH, Jones S, Hu K, Spiegel D.

J Womens Health (Larchmt). 2010 Jul;19(7):1271-80. doi: 10.1089/jwh.2009.1673.

PMID:
20509787
35.

Developing and validating process measures of health care quality: an application to alcohol use disorder treatment.

Harris AH, Kivlahan DR, Bowe T, Finney JW, Humphreys K.

Med Care. 2009 Dec;47(12):1244-50. doi: 10.1097/MLR.0b013e3181b58882.

PMID:
19786908
36.

HEDIS initiation and engagement quality measures of substance use disorder care: impact of setting and health care specialty.

Harris AH, Bowe T, Finney JW, Humphreys K.

Popul Health Manag. 2009 Aug;12(4):191-6. doi: 10.1089/pop.2008.0028.

PMID:
19663621
37.

Meta-analyses and the search for specific and common mediators of substance misuse intervention effects.

Finney JW.

Addiction. 2009 May;104(5):716-7; discussion 717-8. doi: 10.1111/j.1360-0443.2009.02572.x. No abstract available.

PMID:
19413786
38.

Distress and pain during pelvic examinations: effect of sexual violence.

Weitlauf JC, Finney JW, Ruzek JI, Lee TT, Thrailkill A, Jones S, Frayne SM.

Obstet Gynecol. 2008 Dec;112(6):1343-50. doi: 10.1097/AOG.0b013e31818e4678.

PMID:
19037045
39.

Brief interventions for alcohol problems: factors that facilitate implementation.

Moyer A, Finney JW.

Alcohol Res Health. 2004-2005;28(1):44-50.

40.

Measuring the quality of substance use disorder treatment: evaluating the validity of the Department of Veterans Affairs continuity of care performance measure.

Harris AH, Humphreys K, Bowe T, Kivlahan DR, Finney JW.

J Subst Abuse Treat. 2009 Apr;36(3):294-305. doi: 10.1016/j.jsat.2008.05.011. Epub 2008 Oct 5.

PMID:
18835678
41.

Does meeting the HEDIS substance abuse treatment engagement criterion predict patient outcomes?

Harris AH, Humphreys K, Bowe T, Tiet Q, Finney JW.

J Behav Health Serv Res. 2010 Jan;37(1):25-39. doi: 10.1007/s11414-008-9142-2.

PMID:
18770044
42.

Do enhanced friendship networks and active coping mediate the effect of self-help groups on substance abuse?

Humphreys K, Mankowski ES, Moos RH, Finney JW.

Ann Behav Med. 1999 Spring;21(1):54-60. doi: 10.1007/BF02895034.

PMID:
18425655
43.

Care coordination to increase referrals to smoking cessation telephone counseling: a demonstration project.

Sherman SE, Takahashi N, Kalra P, Gifford E, Finney JW, Canfield J, Kelly JF, Joseph GJ, Kuschner W.

Am J Manag Care. 2008 Mar;14(3):141-8.

44.

Matching clients to psychosocial treatments: at the cusp of hope and evidence?

Finney JW.

Addiction. 2008 Feb;103(2):239-40. doi: 10.1111/j.1360-0443.2007.02117.x. No abstract available.

PMID:
18199301
45.

Regression to the mean in substance use disorder treatment research.

Finney JW.

Addiction. 2008 Jan;103(1):42-52. Epub 2007 Nov 12. Review.

PMID:
17999707
46.
47.

Screening psychiatric patients for illicit drug use disorders and problems.

Tiet QQ, Finney JW, Moos RH.

Clin Psychol Rev. 2008 Apr;28(4):578-91. Epub 2007 Sep 8. Review.

PMID:
17900773
48.

Veterans Affairs facility performance on Washington Circle indicators and casemix-adjusted effectiveness.

Harris AH, Humphreys K, Finney JW.

J Subst Abuse Treat. 2007 Dec;33(4):333-9. Epub 2007 Apr 2.

PMID:
17400416
49.

Treatment setting and baseline substance use severity interact to predict patients' outcomes.

Tiet QQ, Ilgen MA, Byrnes HF, Harris AH, Finney JW.

Addiction. 2007 Mar;102(3):432-40.

PMID:
17298651
50.

Coping, symptoms, and functioning outcomes of patients with posttraumatic stress disorder.

Tiet QQ, Rosen C, Cavella S, Moos RH, Finney JW, Yesavage J.

J Trauma Stress. 2006 Dec;19(6):799-811.

PMID:
17195979

Supplemental Content

Loading ...
Support Center